PT  - JOURNAL ARTICLE
AU  - Moggré, S.
AU  - ten Doesschate, T.
AU  - Sieswerda, E.
AU  - Romijnders, K.A.G.J.
TI  - Exploring factors for meaningful patient involvement in infectious disease clinical studies: A qualitative pilot study among key stakeholders
AID  - 10.1101/2023.09.01.23294944
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.09.01.23294944
4099  - http://medrxiv.org/content/early/2023/09/01/2023.09.01.23294944.short
4100  - http://medrxiv.org/content/early/2023/09/01/2023.09.01.23294944.full
AB  - Introduction The attitude towards patient involvement in clinical research has changed dramatically over the years, from research about patient to research with patients. This qualitative study aimed to explore perceptions, ideas, and opinions of stakeholders about integrating the patient perspective into clinical research in infectious diseases in the Netherlands.Methods Stakeholders involved with clinical research in infectious diseases were purposefully sampled between March and June 2023. Interviews were conducted using a semi-structured guide based on the Consolidated Framework for Intervention Research and feasibility framework.Results Of the thirteen stakeholders, six were (clinical) researchers, two represented pharmaceutical companies, two were involved with policy making, and three were patient representatives. Patient involvement in the design and conduct of clinical research in infectious diseases was seen as crucial, although the mode of involvement could differ between research in acute and chronic infections. Stakeholders observed a gap among patients and clinical researchers, which was believed to lead to a phenomenon described as an ivory tower. Key opinion leaders may potentially bridge these barriers and serve as protagonists for meaningful patient involvement. Stakeholders acknowledged the need of communication and expertise to integrate the patient perspective in clinical research in infectious diseases.Conclusion Our qualitative analysis underlines that despite barriers, such as communication and expertise, stakeholders recognize the importance of integrating the patient perspective in clinical research in infectious diseases to improve the quality, relevance, recruitment, and dissemination. Further research is needed to address distinctions between acute and chronic infectious diseases in terms of patient involvement.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by UMC UtrechtAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of the University Medical Center Utrecht (U(MCU) gave ethical approval for this work (code:23U-0086)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesOnly the authors have access to the raw data quoted in this study due to confidentiality. Any reasonable request for access to material relating to the study can be made directly to the corresponding author, who will decide on information sharing on a case-by-case basis.